Patents Assigned to AVACA PHARMA PRIVATE LIMITED
  • Patent number: 11833141
    Abstract: The present disclosure provides a pharmaceutical composition comprising H1 antagonist or a salt or a hydrate or a solvate thereof: a diluent; a solvent; an emollient; a humectant; a preservative; an emulsifier; and a surfactant, said composition being formulated as a topical formulation. The composition may include one or more additional active agents. The composition is formulated into a topical lotion, solution, spray, emulsion, emulsion of water and oil (oil in water or water in oil emulsion), gel, or cream. The compositions of the present disclosure may find utility in treatment of allergic conditions/diseases of skin. It further relates to a method of treating an allergic condition using the compositions of the present disclosure.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: December 5, 2023
    Assignee: Avaca Pharma Private Limited
    Inventor: Mahesh Kandula
  • Publication number: 20230020927
    Abstract: The present disclosure provides a pharmaceutical composition comprising H1 antagonist or a salt or a hydrate or a solvate thereof: a diluent; a solvent; an emollient; a humectant; a preservative; an emulsifier; and a surfactant, said composition being formulated as a topical formulation. The composition may include one or more additional active agents. The composition is formulated into a topical lotion, solution, spray, emulsion, emulsion of water and oil (oil in water or water in oil emulsion), gel, or cream. The compositions of the present disclosure may find utility in treatment of allergic conditions/diseases of skin. It further relates to a method of treating an allergic condition using the compositions of the present disclosure.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 19, 2023
    Applicant: AVACA PHARMA PRIVATE LIMITED
    Inventor: Mahesh Kandula